Medherant is a clinical-stage drug delivery company developing products for pain and CNS diseases. It provides a drug-in-adhesive transdermal delivery system, the TEPI Patch. The company also undertakes studies for other companies to investigate whether their drugs can be formulated for transdermal delivery using TEPI technology.
Type | Private | |
Founded | 2015 | |
HQ | Coventry, GB | Map |
Website | medherant.co.uk |
Employees (est.) (Jan 2021) | 13 | |
Cybersecurity rating | C | More |
Founding Date | 2015 |
Medherant total Funding | $7.6 m |
Medherant latest funding size | $2.55 m |
Time since last funding | 2 years ago |
Medherant investors | Mercia Technologies, Innovate UK |
Medherant has 162 Twitter Followers. The number of followers has decreased 0.9% month over month and decreased 0.5% quarter over quarter
When was Medherant founded?
Medherant was founded in 2015.
Who are Medherant key executives?
Medherant's key executives are Ken Cunningham, Nigel Theobald and John Burt.
How many employees does Medherant have?
Medherant has 13 employees.
Who are Medherant competitors?
Competitors of Medherant include Sartorius Stedim Biotech, Ecomed and DCC Vital.
Where is Medherant headquarters?
Medherant headquarters is located at War Memorial Park, Kenilworth Rd, Coventry.
Where are Medherant offices?
Medherant has an office in Coventry.
How many offices does Medherant have?
Medherant has 1 office.
Receive alerts for 300+ data fields across thousands of companies